Cargando…
A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
BACKGROUND/OBJECTIVES: Lipopolysaccharide-binding protein (LBP), a biomarker of gut barrier permeability to lipopolysaccharides, is higher in adults with obesity and type 2 diabetes. Behavioral weight loss and metformin have distinct effects on the gut microbiome, but their impact on gut permeabilit...
Autores principales: | Tilves, Curtis, Yeh, Hsin-Chieh, Maruthur, Nisa, Juraschek, Stephen P., Miller, Edgar, Appel, Lawrence J., Mueller, Noel T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881332/ https://www.ncbi.nlm.nih.gov/pubmed/34987204 http://dx.doi.org/10.1038/s41366-021-01039-2 |
Ejemplares similares
-
Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial
por: Tilves, Curtis, et al.
Publicado: (2022) -
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial
por: Mueller, Noel T., et al.
Publicado: (2021) -
Effects of a Behavioral Weight Loss Intervention and Metformin Treatment on Serum Urate: Results from a Randomized Clinical Trial
por: Hu, Jiun-Ruey, et al.
Publicado: (2021) -
Metformin Use in Prediabetes Among U.S. Adults, 2005–2012
por: Tseng, Eva, et al.
Publicado: (2017) -
Erratum. Metformin Use in Prediabetes Among U.S. Adults, 2005–2012. Diabetes Care 2017;40:887–893
por: Tseng, Eva, et al.
Publicado: (2018)